![Toshimi Miyoshi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Toshimi Miyoshi
Directeur/Bestuurslid bij FUNPEP COMPANY LIMITED
Vermogen: 1 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Toshimi Miyoshi
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Toshimi Miyoshi via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
RAQUALIA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree | |
Keio University | College/University | Graduate Degree | |
Lexwell Partners | Founder | ||
REGiMMUNE Corp.
![]() REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Okinawa Protein Tomography Ltd.
![]() Okinawa Protein Tomography Ltd. Miscellaneous Commercial ServicesCommercial Services Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
ANGES, INC. | Pharmaceuticals: Generic | Director/Board Member | |
TOWA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
SOLASIA PHARMA K.K. | Pharmaceuticals: Major | Director/Board Member | |
KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Japan | 10 |
Verenigde Staten | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Operationeel
Director/Board Member | 11 |
Independent Dir/Board Member | 5 |
Graduate Degree | 2 |
Founder | 2 |
Corporate Officer/Principal | 1 |
Sterkste connecties
Insiders | |
---|---|
Akimitsu Hirai | 7 |
Norikazu Eiki | 5 |
Hideki Tomioka | 1 |
Taketoshi Hayashi | 1 |
- Beurs
- Insiders
- Toshimi Miyoshi
- Bedrijfsconnecties